V
Market Data
$6.24+$0.21 (+3.48%)
VNDA · Last trade
Prev Close
$6.03
Range (29d)
$5.73 – $6.58
Recent Filings
- 8-K166.6 KBVanda Pharmaceuticals Inc.Jun 5, 4:38 PM ET·0001628280-26-041298
- 10-Q6.4 MBVanda Pharmaceuticals Inc.May 7, 7:01 AM ET·0001628280-26-031667
- 8-K339.6 KBVanda Pharmaceuticals Inc.May 6, 4:06 PM ET·0001628280-26-031241
- 8-K240.0 KBVanda Pharmaceuticals Inc.Apr 22, 5:23 PM ET·0001628280-26-026642
- 8-K144.3 KBVanda Pharmaceuticals Inc.Apr 2, 4:30 PM ET·0001628280-26-023222
- 8-K146.3 KBVanda Pharmaceuticals Inc.Mar 10, 4:47 PM ET·0001628280-26-016516
- 8-K273.8 KBVanda Pharmaceuticals Inc.Feb 23, 7:00 AM ET·0001628280-26-010376
- 8-K222.7 KBVanda Pharmaceuticals Inc.Feb 19, 4:31 PM ET·0001628280-26-009805
- 10-K12.4 MBVanda Pharmaceuticals Inc.Feb 12, 7:04 AM ET·0001628280-26-007460
- 8-K391.6 KBVanda Pharmaceuticals Inc.Feb 11, 4:05 PM ET·0001628280-26-007256
Insiders
10- BATE KENNETHDirector
- BLAIR JAMES C10% Owner
- Baroldi PaoloSVP & Chief Medical Officer
- Birznieks GuntherSVP, Business Development
- CARE CAPITAL II LLC10% Owner
- CARE CAPITAL INVESTMENTS II LP10% Owner
- COLA MICHAEL FDirector
- Chrousos PhaedraDirector
- Clark William DSr. VP, Chief Business Officer
- DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Member of 10% Group
Tickers
Addresses
business
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037
mailing
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037